Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3736 AL 3750

The Effects of Non-Pharmacological Therapies for Dysphagia in Parkinson's Disease: A Systematic Review

Ning F, Lv S, Liu W, Zhang X, Zhao G, Ning W, Liu Z, Yan H, Qin L, Li H, Xu Y.

J Integr Neurosci. 2024 Nov 15;23(11):204. doi: 10.31083/j.jin2311204.

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: molecular mechanisms, biomarkers, diagnosis, and therapies, volume III

Jiang J, Shi K, Hettie KS, Hsu CY, Kung WM.

Front Aging Neurosci. 2024 Jan 8;15:1352988. doi: 10.3389/fnagi.2023.1352988. eCollection 2023.

The Utility of Long-Read Sequencing in Diagnosing Genetic Autosomal Recessive Parkinson's Disease: a genetic screening study

Daida K, Yoshino H, Malik L, Baker B, Ishiguro M, Genner R, Paquette K, Li Y, Nishioka K, Masuzugawa S, Hirano M, Takahashi K, Kolmogolv M, Billingsley KJ, Funayama M, Blauwendraat C, Hattori N.

medRxiv [Preprint]. 2024 Jun 15:2024.06.14.24308784. doi: 10.1101/2024.06.14.24308784.

The effects of transcranial magnetic stimulation for freezing of gait in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

Liu Z, Wen X, Xie X, Liu Y, Tan C, Kuang S, Liu H.

Front Aging Neurosci. 2024 Feb 2;16:1304852. doi: 10.3389/fnagi.2024.1304852. eCollection 2024.

The impact of aerobic exercise dose based on ACSM recommendations on patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

Cui W, Hu Z, Li J, Wang S, Xu R.

Front Aging Neurosci. 2024 Oct 3;16:1419643. doi: 10.3389/fnagi.2024.1419643. eCollection 2024.

Implication of nutrition in severity of symptoms and treatments in quality of life in Parkinson's disease: a systematic review

Mentxakatorre NA, Tijero B, Acera MÁ, Fernández-Valle T, Ruiz-Lopez M, Gómez-Esteban JC, Del Pino R.

Front Nutr. 2024 Oct 8;11:1434290. doi: 10.3389/fnut.2024.1434290. eCollection 2024.

Changes of brain-derived neurotrophic factor (BDNF) levels after different exercise protocols: a systematic review of clinical studies in Parkinson's disease

Paterno A, Polsinelli G, Federico B.

Front Physiol. 2024 Feb 20;15:1352305. doi: 10.3389/fphys.2024.1352305. eCollection 2024.

Parkinson's disease motor intervention patterns: a network meta-analysis based on patient motor function

Zhao H, Zhang L, Yang J, Guo W, Sun C, Shi R, Wang Z.

Front Neurol. 2024 Sep 5;15:1432256. doi: 10.3389/fneur.2024.1432256. eCollection 2024.

Use of phytocanabinoids in animal models of Parkinson's disease: Systematic review

Alves ADF, Dias FCR, Cadena PG, Silva-Jr VA.

Neurotoxicology. 2024 Dec;105:34-44. doi: 10.1016/j.neuro.2024.08.002. Epub 2024 Aug 23.

Optimization of Parkinson's disease therapy with plant extracts and nutrition's evolving roles

Abolarin PO, Amin A, Nafiu AB, Ogundele OM, Owoyele BV.

IBRO Neurosci Rep. 2024 May 24;17:1-12. doi: 10.1016/j.ibneur.2024.05.011. eCollection 2024 Dec.

Nurses, Clergy, Chaplains, Parkinson's Disease, Workplace Religiosity, Women's Health and Family Issues

Carey LB, Cohen J, Drummond D, Aiken C, Koenig HG, Hill T, Gabbay E, Carey JR, Paal P.

J Relig Health. 2024 Jun;63(3):1705-1709. doi: 10.1007/s10943-024-02047-y.

Circulating blood circular RNA in Parkinson's Disease; a systematic study

Beric A, Sun Y, Sanchez S, Martin C, Powell T, Adrian Pardo J, Sanford J, Botia JA, Cruchaga C, Ibanez L.

medRxiv [Preprint]. 2024 Jan 23:2024.01.22.24301623. doi: 10.1101/2024.01.22.24301623.

Gene expression asymmetry in Parkinson's Disease; variation of CCT and BEX gene expression levels are correlated with hemisphere specific severity

Pierce SE, van der Schans EJC, Ensink E, Coetzee GA.

bioRxiv [Preprint]. 2024 Jul 4:2024.07.02.601704. doi: 10.1101/2024.07.02.601704.

Parkinson's Disease Pathogenic Variants: Cross-Ancestry Analysis and Microarray Data Validation

Hong S, Koretsky MJ, Lichtenberg J, Leonard H, Pitz V; Global Parkinson’s Genetics Program (GP2).

medRxiv [Preprint]. 2024 Dec 17:2024.12.16.24319097. doi: 10.1101/2024.12.16.24319097.

Inhibition of Indirect Pathway Activity Causes Abnormal Decision-Making In a Mouse Model of Impulse Control Disorder in Parkinson's Disease

Zhuang X, Lemak J, Sridhar S, Nelson AB.

bioRxiv [Preprint]. 2024 Nov 1:2024.02.19.581062. doi: 10.1101/2024.02.19.581062.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias